Post-Covid disorders of nervous system: personal experience
- Authors: Shchepankevitch L.A.1,2,3, Arkhipov I.E.1,2, Polyanskaya V.V.1,2, Veretelnikov I.A.2, Taneeva E.V.2, Rerikh K.V.1,2
-
Affiliations:
- Novosibirsk State Medical University
- State Novosibirsk Regional Clinical Hospital
- Federal Research Center of Fundamental and Translational Medicine
- Issue: Vol 17, No 1 (2023)
- Pages: 82-86
- Section: Clinical analysis
- URL: https://journals.rcsi.science/2075-5473/article/view/125992
- DOI: https://doi.org/10.54101/ACEN.2023.1.10
- ID: 125992
Cite item
Full Text
Abstract
Introduction. In the COVID-19 pandemic, high lethality as well as long-term outcomes are getting more and more relevant. According to the accumulated study results, COVID-19 affects the nervous system both directly and indirectly.
Objective: to study the variants of post-COVID syndrome based on the data from the State Novosibirsk Regional Clinical Hospital from July 2020 to February 2022.
Materials and methods. We have performed post hoc analysis of the medical records of 1,500 patients with a past history of COVID-19 admitted following various neurological disorders manifested from July 2020 to February 2022.
Results. While temporary and pathogenetic association with past COVID-19 was revealed in 455 patients, primary involvement of the central nervous system was reported in 91.6% of cases, primary involvement of the peripheral nervous system — in 8.1% of cases, and musculoskeletal disorder (idiopathic myodystrophy) — in 0.3% of cases.
Conclusion. Prevalence of the neurological variants of post-COVID syndrome is still unknown. However, patients with severe COVID-19 are more susceptible to neurological complications during the following six months.
Full Text
##article.viewOnOriginalSite##About the authors
Larisa A. Shchepankevitch
Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital; Federal Research Center of Fundamental and Translational Medicine
Author for correspondence.
Email: shepankevich@rambler.ru
ORCID iD: 0000-0001-6951-2205
D. Sci. (Med.), Assocoated Professor, Head, Neurology Department, Novosibirsk State Medical University; Curator, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital; Main Researcher, Federal Research Center of Fundamental and Translational Medicine
Russian Federation, Novosibirsk; Novosibirsk; NovosibirskIvan E. Arkhipov
Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital
Email: shepankevich@rambler.ru
ORCID iD: 0000-0003-2740-6388
Neurologist, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital
Russian Federation, Novosibirsk; NovosibirskVeronika V. Polyanskaya
Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital
Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-5122-2549
Student, Novosibirsk State Medical University; Assistant of Neurologist, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital
Russian Federation, Novosibirsk; NovosibirskIvan A. Veretelnikov
State Novosibirsk Regional Clinical Hospital
Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-8587-5679
Chief, 8th Neurology Department, State Novosibirsk Regional Clinical Hospital
Russian Federation, NovosibirskElena V. Taneeva
State Novosibirsk Regional Clinical Hospital
Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-6538-6069
Chief, Regional Vascular Center No. 2, State Novosibirsk Regional Clinical Hospital
Russian Federation, NovosibirskKsenya V. Rerikh
Novosibirsk State Medical University; State Novosibirsk Regional Clinical Hospital
Email: shepankevich@rambler.ru
ORCID iD: 0000-0002-4141-9161
Neurologist, Regional Vascular Center No. 2, State Novosibirsk Regional Clinical Hospital
Russian Federation, Novosibirsk; NovosibirskReferences
- Lopez-Leon S., Wegman-Ostrosky T., Perelman C. et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021; 11(1): 16144. doi: 10.1038/s41598-021-95565-8
- Mao L., Jin H., Wang M. et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683–690. doi: 10.1001/jamaneurol.2020.1127
- Román G.C., Gracia F., Torres A. et al. Acute Transverse Myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front. Immunol. 2021; (12): 653786. doi: 10.3389/fimmu.2021.653786
- Stefanou M.I., Palaiodimou L., Bakola E. et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther. Adv. Chronic Dis. 2022; 13: 20406223221076890. doi: 10.1177/20406223221076890
- Brann D.H., Tsukahara T., Weinreb C. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020; 6(31): eabc5801. doi: 10.1126/sciadv.abc5801
- Танашян М.М., Кузнецова П.И., Раскуражев А.А. Неврологические аспекты СOVID-19. Анналы клинической и экспериментальной неврологии. 2020; 14(2): 62–69. Tanashyan M.M., Kuznetsova P.I., Raskurazhev A.A. Neurological aspects of COVID-19. Annals of clinical and experimental neurology 2020; 14(2): 62–69. (In Russ.) doi: 10.25692/ACEN.2020.2.8
- Barrantes F.J. Central nervous system targets and routes for SARS-CoV-2: current views and new hypotheses. ACS Chem. Neurosci. 2020; 11(18): 2793–2803. doi: 10.1021/acschemneuro.0c00434
- Palaiodimou L., Stefanou M.I., Katsanos A.H. et al. Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: a systematic review and meta-analysis. Eur. J. Neurol. 2021; 28(10): 3517–3529. doi: 10.1111/ene.14860
- Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020; 16: 636–644. doi: 10.1038/s41582-020-0398-3
- Graham E.L., Clark J.R., Orban Z.S. et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 “long haulers”. Ann. Clin. Transl. Neurol. 2021; 8(5): 1073–1085. doi: 10.1002/acn3.51350
- Jose R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir. Med. 2020; 8(6): e46–e47. doi: 10.1016/S2213-2600(20)30216-2
- Lechien J.R., Chiesa-Estomba C.M., De Siati D.R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. 2020; 277(8): 2251–2261. doi: 10.1007/s00405-020-05965-1
- Mainali S., Darsie M.E. Neurologic and neuroscientific evidence in aged COVID-19 patients. Front. Aging Neurosci. 2021; 13: 648662. doi: 10.3389/fnagi.2021.648662
- Wang F., Kream R.M., Stefano G.B. Long-term respiratory and neurological sequelae of COVID-19. Med. Sci. Monit. 2020; 26: e928996. doi: 10.12659/MSM.928996
- Белопасов В.В., Яшу Я., Самойлова Е.М., Баклаушев В.П. Поражение нервной системы при СOVID-19. Клиническая практика. 2020; 11(2): 60–80. Belopasov V.V., Yachou Ya., Samoilova E.M., Baklaushev V.P. The nervous system damage in COVID-19. Journal of Clinical Practice. 2020; 11(2): 60–80. (In Russ.) doi: 10.17816/clinpract34851
- Taquet M., Geddes J.R., Husain M. et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5): 416–427. doi: 10.1016/S2215-0366(21)00084-5
![](/img/style/loading.gif)